1. Home
  2. DERM vs TPVG Comparison

DERM vs TPVG Comparison

Compare DERM & TPVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Journey Medical Corporation

DERM

Journey Medical Corporation

HOLD

Current Price

$7.45

Market Cap

190.3M

Sector

Health Care

ML Signal

HOLD

Logo TriplePoint Venture Growth BDC Corp.

TPVG

TriplePoint Venture Growth BDC Corp.

HOLD

Current Price

$5.39

Market Cap

224.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
DERM
TPVG
Founded
2014
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
190.3M
224.9M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
DERM
TPVG
Price
$7.45
$5.39
Analyst Decision
Strong Buy
Hold
Analyst Count
3
5
Target Price
$12.67
$5.90
AVG Volume (30 Days)
209.9K
190.3K
Earning Date
05-13-2026
05-06-2026
Dividend Yield
N/A
17.66%
EPS Growth
34.72
N/A
EPS
N/A
0.43
Revenue
$61,858,000.00
N/A
Revenue This Year
$39.72
$7.67
Revenue Next Year
$63.24
N/A
P/E Ratio
N/A
$12.42
Revenue Growth
10.20
N/A
52 Week Low
$4.31
$4.40
52 Week High
$9.56
$6.95

Technical Indicators

Market Signals
Indicator
DERM
TPVG
Relative Strength Index (RSI) 61.47 61.89
Support Level $7.39 $5.07
Resistance Level $8.29 $5.39
Average True Range (ATR) 0.44 0.11
MACD 0.09 -0.01
Stochastic Oscillator 68.27 40.35

Price Performance

Historical Comparison
DERM
TPVG

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.

About TPVG TriplePoint Venture Growth BDC Corp.

TriplePoint Venture Growth BDC Corp is a closed-end, non-diversified management investment company. Its investment objective is to maximize its total return to stockholders in the form of current income and, to a lesser extent, capital appreciation. The fund focuses on companies operating in the fields of biofuels, business applications software, wireless communications equipment, e-commerce, clothing and accessories, conferencing equipment and services, personal goods, financial institutions and services, entertainment, mixed retailing, and healthcare services. Geographically, all the firm's operations are located across the United States.

Share on Social Networks: